3.8 Article

Pro-angiogenic Properties of Terbium Hydroxide Nanorods: Molecular Mechanisms and Therapeutic Applications in Wound Healing

期刊

ACS BIOMATERIALS SCIENCE & ENGINEERING
卷 3, 期 12, 页码 3635-3645

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsbiomaterials.7b00457

关键词

terbium hydroxide nanorods; angiogenesis; mouse model; wound healing; nonimmunogenic

资金

  1. CSIR, New Delhi from DST-Nanomission project [SR/NM/NS-1252/2013, GAP 570]
  2. CSIR 12th FYP project entitled 'CSIR-Mayo Clinic Collaboration for Innovation and Translational Research' [CKM/CMPP-09, MLP0020]
  3. UGC, New Delhi
  4. CSIR, New Delhi
  5. DST, New Delhi

向作者/读者索取更多资源

The process of angiogenesis, involving generation of new blood vessels from the existing ones, is vital for the supply of oxygen and nutrients to various tissues of body system. Angiogenesis is directly associated with several physiological and pathological processes. It is well-established that impairment in angiogenesis process results in various fatal conditions. Recently, few research groups including ours demonstrated therapeutic angiogenesis through nanomedicine approach using metal oxide/hydroxide nanoparticles. However, there is still a thorough necessity for the development of novel, eco-friendly, pro-angiogenic nanomaterials. Hence, in the present study we demonstrate the in vitro and in vivo pro-angiogenic properties of terbium hydroxide nanorods (THNRs) synthesized using an advanced microwave irradiation method, along with the detailed molecular signaling cascade underlying THNRs induced angiogenesis. The in vivo wound healing and nonimmunogenicity of the THNRs have been validated in the mouse models. We thus strongly believe that the present study establishing the pro-angiogenic properties of THNRs will aid in the development of alternative treatment strategies for wound healing along with cardiovascular and ischemic diseases, where angiogenesis is the chief target.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据